FDA alerts providers to lack of sterility in NuVision Pharmacy products

Share this article:

The Food and Drug Administration expanded an alert about NuVision Pharmacy of Dallas, TX, on Saturday. It said investigators found poor sterile production practices that raised concern about a lack of sterility assurance for the company's sterile drug products.

NuVision recalled methylcobalamin injection (a form of Vitamin B12 injection) and lyophilized injection (freeze-dried powder) products in April because of a lack of sterility assurance and problems with quality control processes. Microbial contamination in a drug product can put a patient or resident at a serious infection risk, the FDA said.

Healthcare providers should check their medical supplies for NuVision sterile products, quarantine them and not give them to patients or residents, the FDA warned. Providers and consumers should report adverse reactions or problems to MedWatch

Share this article:
close

Next Article in Products

More in Products

LINK Innovation Competition crowns Walalight best

The Walalight™ system, which simulates natural sunlight exposure and promotes regular circadian rhythms, won first place at the 2014 LINK Innovation Competition on Monday in Chicago.

Nestlé Professional MINOR adds low-sodium, gluten-free base

Nestlé Professional MINOR adds low-sodium, gluten-free base

MINOR's Low Sodium Gluten Free Base is available in chicken, beef and vegetable, Nestle Professional announced.

Larson Electronics debuts mobile power distribution system

Larson Electronics debuts mobile power distribution system

The Larson Electronics MDC-240-100MB-8X120 temporary power distribution system is now available for those who need to use power sources independently of a work area.